Halo Labs products

The Aura™ system is the particle analysis platform that gets you to your best formulation faster. It combines Fluorescence Membrane Microscopy (FMM) technology with Backgrounded Imaging (BMI) technology to give you a low volume, high-throughput system that counts, sizes, and IDs protein aggregates. Translation? You can now screen particles as early as lead optimization and pre-formulation testing to gain key drug stability insights earlier, reducing development risk and time to market.

Aura GT™ helps you realize the promise of gene therapies, without using a lot of your viral vector sample throughout the development process. Avoid conditions and formulations that facilitate viral vector aggregates, monitor DNA leakage, and ensure product quality with just 5 µL of sample per data point. Use Fluorescence Membrane Microscopy (FMM) and Backgrounded Imaging (BMI) technology to get accurate and quantitative particle size, count, morphology, and ID info. Avoid adverse immunogenetic events that can arise due to subvisible particles (SVPs) and measure the stability of the capsid to determine the shelf-life and efficacy of your product – with just 5 µL!

Aura PTx™ gets you to your best formulation faster! Backgrounded Imaging (BMI) technology to give you accurate count, size, and morphology information about particles in your sample. Couple that with Fluorescence Membrane Microscopy (FMM), which gives you definitive ID of protein aggregates and an easy way to monitor polysorbate degradation. And did we mention you could do all of this with just 5 µL of sample and get data for 96 samples in few hours, not days? Hundreds of conditions can be analyzed early on, allowing scientists to gain key insights into drug stability to reduce development risk and time to market.